SimiTree Unveils AI Tool SARA to Revolutionize Home Health Chart Review and Coding
SimiTree, a provider of revenue cycle, coding, and consulting services for the post-acute and behavioral health industries, has launched SARA (SimiTree Assessment Review AI), an artificial intelligence platform aimed at enhancing clinical documentation review, coding accuracy, and operational efficiency for home health agencies. SimiTree is a portfolio company of Sheridan Capital Partners. SARA was developed using decades of clinical experience and trained on more than one million medical charts. Designed specifically for clinicians, the platform empowers healthcare professionals to conduct more accurate and efficient chart reviews. According to Bill Simione, CEO and Managing Principal at SimiTree, SARA represents a breakthrough in coding and documentation support for home health, offering a smarter and faster approach. Home health agencies are dealing with increased documentation requirements, staffing shortages, rising compliance demands, and potential Medicare reimbursement cuts in 2026. SARA addresses these challenges by combining expert human review with advanced AI capabilities. The platform, supported by a team with 15 years of experience in coding and OASIS services, helps agencies reduce costs and improve outcomes. “We created SARA to directly tackle the operational and financial challenges that home health agencies face daily,” said David Berman, COO of SimiTree. “It offers a scalable, intelligent solution that eases the administrative workload, speeds up turnaround times, and provides real-time coding and OASIS insights to drive better results.” SARA significantly reduces the time required to complete chart reviews, cutting it in half compared to traditional methods while maintaining high-quality standards. It accurately identifies ICD-10 primary and comorbidity codes, optimizes OASIS scoring, and detects inconsistencies before charts are finalized. This helps minimize denials and improve first-pass acceptance rates. The platform is backed by SimiTree’s quality assurance team of clinical nurses. Unlike conventional software implementations, SimiTree’s service requires no additional infrastructure or staff training, enabling agencies to see immediate results and focus resources on growth and patient care. SimiTree, a company under Sheridan Capital Partners, specializes in tech-enabled, niche revenue cycle management, coding, consulting, staffing, and managed services for home health, hospice, and behavioral health organizations. By integrating deep industry knowledge with cutting-edge technology, SimiTree supports healthcare providers in optimizing operations, ensuring compliance, and achieving long-term growth. More information can be found at www.simitreehc.com. Sheridan Capital Partners is a private equity firm based in Chicago that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. The firm invests in sectors such as healthcare providers and services, healthcare IT, outsourced services, consumer health, and medical products. It aims to provide strategic resources to help companies grow, create lasting value, and achieve strong performance. Learn more at www.sheridancp.com.